Gender disparities with the use of percutaneous left ventricular assist device in patients undergoing percutaneous coronary intervention complicated by cardiogenic shock: From pVAD Working Group
Background: Hemodynamic support with Impella (Abiomed Inc., Danvers, MA) devices is becoming a more prevalent treatment option for patients with cardiogenic shock (CS) undergoing percutaneous coronary intervention (PCI). There exists only limited published data regarding outcome differences between...
Main Authors: | Rajkumar Doshi, Krunalkumar Patel, Dean Decter, Rajiv Jauhar, Perwaiz Meraj |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-07-01
|
Series: | Indian Heart Journal |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0019483218300798 |
Similar Items
-
Use of Impella 2.5 in Patient with Multi-Vessel Percutaneous Coronary Intervention and Cardiogenic Shock
by: Rajkumar Doshi, et al.
Published: (2017-08-01) -
Percutaneous Mechanical Support in Cardiogenic Shock: A Review
by: Fahad Syed Gilani, et al.
Published: (2015-05-01) -
Percutaneous Mechanical Support in Cardiogenic Shock: A Review
by: Fahad Syed Gilani, et al.
Published: (2015-01-01) -
Outcome of patients with non‐ischaemic cardiogenic shock supported by percutaneous left ventricular assist device
by: Jean M. Haurand, et al.
Published: (2021-10-01) -
Complete percutaneous myocardial revascularization in patients with STEMI complicated by cardiogenic shock
by: Petrović Milovan, et al.
Published: (2019-01-01)